Gene ther­a­py goes acoustic as ARCH-backed biotech launch­es with ul­tra­sound gene de­liv­ery plat­form

3 years ago
Financing
Cell/Gene Tx

Verve re­veals let­ter from FDA that lays out con­di­tions to lift base edit­ing tri­al hold

3 years ago
R&D
FDA+

Up­dat­ed: Ar­bi­tra­tor awards $157M to Soon-Sh­iong's Im­mu­ni­ty­Bio in dis­pute with Sor­ren­to

3 years ago
Law

Ver­tex-part­nered gene ther­a­py biotech Affinia scraps IPO plans

3 years ago
Financing
Startups

Af­ter M&A fell through, Ther­a­peu­tic­sMD sells hor­mone ther­a­py, con­tra­cep­tive ring for $140M cash plus roy­al­ties

3 years ago
Deals

Val­neva's chikun­gun­ya vac­cine on track for FDA nod af­ter long-term an­ti­body da­ta

3 years ago
R&D

Am­gen, years be­hind ri­vals, says PhI obe­si­ty drug shows dura­bil­i­ty signs

3 years ago
R&D
Pharma

Big week for Alzheimer’s da­ta; As­traZeneca buys cell ther­a­py start­up; Dig­i­tal ther­a­peu­tics hits a pay­er wall; and ...

3 years ago
Weekly

Bay­er starts work on $43M+ ex­pan­sion of OTC man­u­fac­tur­ing site in Penn­syl­va­nia

3 years ago
Financing
Pharma

US month­ly costs for biosim­i­lars 'sub­stan­tial­ly high­er' than Ger­many or Switzer­land, JA­MA re­search finds

3 years ago
Pharma

Gilead spot­lights HIV projects and the com­mu­ni­ty lead­ers dri­ving them in new mi­ni-doc­u­men­tary films

3 years ago
Pharma
Marketing

Bris­tol My­ers, Ab­b­Vie drugs shake up first-line pre­scrib­ing among gas­troen­terol­o­gists — re­port

3 years ago
Pharma
Marketing

'Where would the world be with­out nurs­es?' J&J re­fresh­es cam­paign hon­or­ing health work­ers

3 years ago
Pharma
Marketing

EMA pulls an opi­oid from the 1950s used to treat dry cough

3 years ago
Pharma

FDA's drug short­ages leader wants com­pa­nies to start re­port­ing in­creas­es in de­mand

3 years ago
Pharma
FDA+

In­sta­gram, Tik­Tok so­cial me­dia in­flu­encers lead health­care and phar­ma spon­sor­ships — sur­vey

3 years ago
Pharma
Marketing

In search for a 'u­ni­ver­sal T cell en­gager', Im­muno­core inks deal with Gilead-backed Gade­ta

3 years ago
Deals

Salarius Phar­ma­ceu­ti­cals sees with­drawals, 3 of 13 pa­tient re­spon­ders in sar­co­ma tri­al

3 years ago
Startups
R&D

Beam's base-edit­ed al­lo­gene­ic CAR-T gets FDA go-ahead af­ter four-month wait

3 years ago
Cell/Gene Tx
FDA+

A fledg­ling biotech goes SPAC route to bankroll can­cer vac­cine, CAR-T and CD47

3 years ago
Financing
Startups

FDA re­jects Y-mAbs’ neu­rob­las­toma drug af­ter tak­ing is­sue with clin­i­cal tri­al de­sign

3 years ago
R&D
FDA+

Philip Tagari switch­es Am­gen's dis­cov­ery lab for in­sitro's ma­chine learn­ing tools; CEO Joaquin Du­a­to to chair J&J's ...

3 years ago
Peer Review

Rigel Phar­ma scores FDA ap­proval for leukemia, kick­ing off show­down with Servi­er in IDH1

3 years ago
FDA+

Pfiz­er backs $60M in­fu­sion in­to Car­rick, teams up on breast can­cer treat­ment

3 years ago
Financing
R&D
First page Previous page 420421422423424425426 Next page Last page
A service from the Financial Times